Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial. (linkinghub.elsevier.com)

Authors: Rouphael N … Frenck RW Jr Journal: Lancet Infectious Diseases Published: 2026-06-30 DOI: https://doi.org/10.1016/S1473-3099(26)00224-0